Sionna Therapeutics, Inc.
NASDAQ:SIONBiotechnology
Healthcare
$2.97 +1.85%
+$0.68 today
- Market cap
- $134.35M
- Beta
- 1.29
- P/E (TTM)
- -19.7
- EPS (TTM)
- -$1.90
52W Low $13.81High $48.45
Volume 0.65M
Average 0.39M
Cash Flow
Check whether earnings turn into cash.
Operating Cash Flow
-$66.30M
FY 2025 · Annual
Investing Cash Flow
-$118.75M
FY 2025 · Annual
Financing Cash Flow
$205.71M
FY 2025 · Annual
+14.9% YoYCash Flow Statement
USD
Free Cash Flow
Net Income to FCF bridge
FY2025
= Net Income-$75.3M
+ D&A-$3.1M
+ Stock-Based Comp$12.1M
+ Deferred Tax$0
- Working Capital-$2.7M
+ Other Non-Cash$2.6M
= Operating Cash Flow-$66.3M
- Capex-$377.0K
= Free Cash Flow-$66.7M
Analysis
FY2025 free cash flow is -$66.7M. FCF conversion is 88.6% of net income. Operating cash flow was -$66.3M, with capex of -$377.0K. The largest bridge item is Stock-Based Comp at $12.1M.
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 10, 2026 | |
| 8-K | Current report | Nov 10, 2026 | |
| SC 13G | SC 13G filing | Nov 9, 2026 | |
| SC 13D/A | SC 13D/A filing | Sep 21, 2026 | |
| 4 | Statement of changes in beneficial ownership | Sep 21, 2026 |
Does SION generate free cash flow?
Sionna Therapeutics, Inc. (SION) generated -$66.67M of free cash flow in fiscal 2025.
How much operating cash flow does SION produce?
Operating cash flow was -$66.30M, before capital expenditures of $377,000.00.
Continue the stock analysis
Jump to another research area for this company.